3 Monster Stocks to Hold for the Next 10 Years

How long do you intend to keep a particular stock after purchasing it? If you follow the method endorsed by Warren Buffett, your preferred duration would be indefinitely (or as close to forever as possible).

A more strategic approach when completing your portfolio is to focus on identifying high-quality companies rather than trying to forecast the short-term success of individual stocks. This perspective encourages you to seek out solid businesses instead.

This long-term way of thinking often leads to better returns.

Occasionally, you’ll find a company’s stock story that is indisputably on the verge of an exceptional expansion spree. Such opportunities frequently emerge following a groundbreaking scientific, technical, or medical discovery.

Over the following decade, it’s worth considering investing in these three stocks that could potentially bring significant returns. While they may outperform beyond this period, the upcoming ten years might be especially profitable. Here’s the rationale behind my suggestion.

1. Roblox

Roblox, represented by the ticker symbol RBLX and holding approximately 5.87% of the market, serves as an extensive online platform for multiplayer video games, enabling numerous participants to engage in the same game concurrently.

Although it may not be what sets it apart, what truly distinguishes Roblox is its innovative feature and business model: enabling players to create their own virtual game rooms, which they can then monetize. In 2024 alone, the company paid out approximately $923 million to creators of these game rooms, who collectively entertained an average of 82.9 million daily players for a total of 73.5 billion play hours throughout the year. These figures represented more than a 20% increase compared to the previous year, continuing a long-standing trend of growth. Given its past success, it’s likely that this growth will persist for several more years.

It’s interesting to note that many popular multiplayer online games such as Fortnite, several installments from the Call of Duty series, and Apex Legends have all seen significant increases in player numbers. However, this growth was later accompanied by a noticeable decrease in player engagement.

In other words, Roblox has withstood the test of time.

The model primarily deserves credit for its success. Although the visuals in its games might be lackluster and the gameplay itself may appear rather basic, there seems to be something appealing about the concept. This could be due to the fact that the designers of these gaming spaces are driven to constantly innovate and keep their offerings engaging.

From my perspective, it’s fascinating to see that while Roblox’s virtual reality metaverse wasn’t as buzzworthy as it once was a few years back, it’s still thriving in various forms. However, its transformation is undeniable, shifting from the vast social platform we initially anticipated towards a more marketing-oriented direction.

In a natural and easy-to-read manner:

Nike’s metaverse offers users the chance to engage with each other through straightforward games showcasing Nike products, like sneakers. Meanwhile, Autodesk, the makers of AutoCAD software, are leveraging virtual reality to enhance the design experience for their users. Roblox’s technology is being applied in numerous projects similar to these.

According to predictions by Straits Research, the global metaverse industry is projected to expand at an annual growth rate exceeding 40%, up until 2032. In other words, the metaverse market is expected to see significant growth over the next decade.

2. Joby Aviation

Not so long ago, the idea of a flying taxi seemed like pure fantasy. Today, it’s a tangible concept. One of the handful of companies bringing this vision to life is Joby Aviation, currently valued at 17.24%.

The emergence of light lithium-powered batteries and potent electric motors has paved the way for electric vehicles, and surprisingly, these technologies also power a nearly silent hybrid aircraft that combines airplane flight with helicopter-like takeoff and landing capabilities. This means that a journey taking over an hour by car can now be achieved in mere minutes.

I’ve been witnessing it unfold right before my eyes – Joby’s prototype aircraft, designed to carry four passengers, is not just a theoretical concept, but a reality that has clocked over 30,000 miles in test flights. The journey towards FAA certification is well underway, with more than half the process completed.

Simultaneously, Joby is forging commercial service partnerships – notably in Dubai, as well as with Virgin Atlantic and Toyota Motor. In fact, Toyota Motor has been a significant shareholder of Joby since last October.

Just recently, President Trump signed an executive order, paving the way for governmental backing of our country’s emerging electric vertical takeoff and landing (eVTOL) and air-taxi industry, which Joby plays a crucial role in.

The timeline for Joby Aviation to achieve commercial viability remains uncertain, but it’s quite evident that the world’s progression aligns favorably with this company. Many anticipated transformations are expected to be completed within the subsequent decade.

According to Global Market Insights, it’s predicted that the global air taxi industry will experience a robust growth rate exceeding 20% per year until 2033. Notably, North America is anticipated to lead as the largest market segment in this industry.

3. CRISPR Therapeutics

Ultimately, consider including CRISPR Therapeutics (with a ticker symbol CRSP and a current increase of 4.68%) in your collection of long-term investment picks for the ensuing decade.

CRISPR stands for “clustered regularly interspaced short palindromic repeats,” which is a term that describes the pattern of a human DNA chain from one end to another. This sequence, as explained on the CRISPR Therapeutics website, enables precise gene editing by making exact cuts in DNA and then utilizing natural repair processes to adjust the gene according to our desired changes.

In simple terms, CRISPR Therapeutics’ Casgevy, used to treat sickle cell disease and transfusion-dependent beta thalassemia, became the first approved gene-editing therapy by the FDA in late 2023, setting an exciting path forward for similar treatments.

As a passionate advocate for CRISPR technology, I can’t help but express my excitement about its potential applications. You see, it’s not just CRISPR that’s being used in genetic repair treatments; many other treatments will also leverage this groundbreaking technology. And let me tell you, these aren’t your run-of-the-mill treatments – they’re heavy hitters!

Currently, six clinical trials are underway within biopharma companies, all testing the same science. Two of these trials focus on cancer, two more on heart disease, and there are several others targeting conditions like diabetes and muscular dystrophy. Additionally, there are numerous pre-clinical studies in progress.

The best part? Some of these clinical trials could start yielding financial returns within the next decade as Casgevy, the company behind this technology, gains momentum. It’s an exciting time to be part of this scientific revolution!

Analysts predict that the company, with a valuation of $5 billion, will achieve approximately $50 million in revenue this year. However, they are expecting sales to significantly increase to nearly $200 million next year, and further grow towards $400 million by 2027. This growth is primarily due to the increasing adoption of its therapies.

It’s possible that this is just the start, as the science behind gene-editing has been validated. According to Precedence Research, the worldwide market for gene-editing drugs could expand at an average rate of 13% per year until 2034. Such consistent growth might help CRISPR Therapeutics transition from operating at a loss to profitability within this timeframe, which would serve as a significant positive factor in its own right.

2025-07-17 16:01

1. Roblox

2. Joby Aviation

3. CRISPR Therapeutics

Read More